135 related articles for article (PubMed ID: 19356275)
21. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
22. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
[TBL] [Abstract][Full Text] [Related]
23. Decreasing Unintended Pregnancy with LARC.
Hitt WC
J Ark Med Soc; 2016 Feb; 112(10):180-1. PubMed ID: 26939469
[No Abstract] [Full Text] [Related]
24. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
25. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
Yao XY; Du MK
Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
[TBL] [Abstract][Full Text] [Related]
26. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.
Lewis LN; Doherty DA; Hickey M; Skinner SR
Contraception; 2010 May; 81(5):421-6. PubMed ID: 20399949
[TBL] [Abstract][Full Text] [Related]
27. Long-acting reversible contraception: reducing unintended pregnancies.
Ruddick C
Community Pract; 2009 Sep; 82(9):24-7. PubMed ID: 19788120
[TBL] [Abstract][Full Text] [Related]
28. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.
Ezegwui HU; Ikeako LC; Ishiekwene CI; Oguanua TC
Niger J Med; 2011; 20(4):448-50. PubMed ID: 22288321
[TBL] [Abstract][Full Text] [Related]
29. Nexplanon® removals in a community sexual and reproductive health service.
Chaudhry F
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):160-1. PubMed ID: 26747656
[No Abstract] [Full Text] [Related]
30. Contraceptive efficacy and side effects of Implanon.
Gezginc K; Balci O; Karatayli R; Colakoglu MC
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
[TBL] [Abstract][Full Text] [Related]
31. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
[TBL] [Abstract][Full Text] [Related]
32. Attitudes towards long-acting reversible methods of contraception in general practice in the UK.
Wellings K; Zhihong Z; Krentel A; Barrett G; Glasier A
Contraception; 2007 Sep; 76(3):208-14. PubMed ID: 17707718
[TBL] [Abstract][Full Text] [Related]
33. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
34. Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016/17.
G/Medhin T; Gebrekidan KG; Nerea MK; Gerezgiher H; Haftu M
BMC Res Notes; 2019 Jan; 12(1):8. PubMed ID: 30616681
[TBL] [Abstract][Full Text] [Related]
35. [Contraceptive implants--aberrations from insertion and removal procedures].
Jørgensen NP
Tidsskr Nor Laegeforen; 2010 Apr; 130(7):733-4. PubMed ID: 20379334
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Implanon insertion and removal.
Levine JP; Sinofsky FE; Christ MF;
Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
[TBL] [Abstract][Full Text] [Related]
37. Insertion and removal of Implanon: practical considerations.
Mascarenhas L
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
[TBL] [Abstract][Full Text] [Related]
38. An assessment of the first 3 years' use of Implanon in Luton.
Agrawal A; Robinson C
J Fam Plann Reprod Health Care; 2005 Oct; 31(4):310-2. PubMed ID: 16274557
[TBL] [Abstract][Full Text] [Related]
39. Medical care cost savings from adolescent contraceptive use.
Trussell J; Koenig J; Stewart F; Darroch JE
Fam Plann Perspect; 1997; 29(6):248-55, 295. PubMed ID: 9429869
[TBL] [Abstract][Full Text] [Related]
40. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
